drugset / Trial / NCT07314281

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

NCT07314281

Phase 4 Recruiting 40 enrolled Indus Hospital and Health Network
RandomizedParallel-groupOpen-labelTreatment

Summary

1. Primary Objective: o To evaluate the efficacy of intravenous azithromycin compared with meropenem in the treatment of extensively drug-resistant (XDR) enteric fever. 2. Secondary Objectives: * To evaluate the fever defervescence and Salmonella Typhi eradication * To evaluate the cost-effectiveness of intravenous azithromycin versus meropenem in treating XDR enteric fever. 3. Exploratory Objectives: * To evaluate the drug resistance against intravenous azithromycin versus in treating XDR enteric fever.

Timeline

Start
2025-04-22
Primary completion
2027-01-15
Completion
2027-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg Intravenous
Comparator Meropenem Small molecule 1000 mg Intravenous

Indications